Cepheid Reports 21 Percent Uptick in Q2 Revenues | GenomeWeb

NEW YORK (GenomeWeb) — Cepheid reported after the close of the market Thursday a 21 percent increase in second quarter revenues as it placed a record number of GeneXpert diagnostic systems during the period.

For the three months ended June 30, Cepheid logged revenues of $116.5 million compared to $96.0 million in Q2 2014, narrowly beating the average Wall Street estimate of $115.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.